Issue - decisions

The Supplemental Substance Misuse Treatment and Recovery Grant 2022 - 2025

29/03/2023 - The Supplemental Substance Misuse Treatment and Recovery Grant 2022 - 2025

Cllr Mark Hawthorne, Leader of the Council, sought ratification by Cabinet for decisions made by the Director of Public Health in consultation with the Cabinet Lead for Public Health and Communities in relation to the Office for Health Improvement and Disparities (OHID) Supplemental Substance Misuse Treatment and Recovery Grant (“SSMTRG”) described in the ‘Extra funding for drug and alcohol treatment 2022 to 2023’ guidance contained in the Background Documents below during financial year 2022/23; and to approve further recommendations in relation to the distribution of the SSMTRG during financial years 2023/24 and, 2024/25 which will be the first year of the new adult treatment contract described in paragraph 15 below.

 

Having considered all of the information, Cabinet noted the report and

 

RESOLVED to:

 

1. Ratify a decision taken by the Director of Public Health, in consultation with the Cabinet Member for Public Health and Communities, to:

 

a. vary the council’s contract with Change, Grow, Live (CGL) relating to the provision of adult community drug and alcohol treatment and recovery services on the following basis:

 

i) by adding additional posts to those currently provided by CGL across a range of evidence-based interventions during financial year 2022/23;

 

ii) by requiring CGL to provide a Buvidal Pilot for 30 service users during financial year 2022/23; and

 

iii) by adding a requirement for CGL to carry out staff training in relation to service users’ co-existing mental health and substance misuse conditions during the financial year 2022/23

 

b. allocate £2,064 in funding from the SSMTRG funding made available by OHID for use in financial year 2022/23 (the 2022/23 SSMTRG) to the part payment of GCC staff costs arising from a qualitative research exercise to be carried out by the council in relation to engagement with Black and Minority Ethnic (BAME) stakeholders (including service users and carers) during the period December 2022 – June 2023.

 

c. vary the council’s contract with Prospects for the supply of Youth Support Services by increasing the charges payable thereunder during the financial year 2022/23 for the purposes of funding the cost of Prospects employing additional staff during such period in order to expand access to young people’s substance misuse services.

 

d. allocate £30,000 by means of a one-off grant from the 2022/23 SSMTRG to a charity offering specialist therapeutic services for families in crisis, namely ‘InfoBuzz’, for the purposes of funding the cost of them employing additional staff during financial year 2022/23 in order to expand access to their services to meet demand.

e. allocate £12,000 by means of a one-off grant from the 2022/23 SSMTRG to a Stroud based charity offering services to young people and their families, namely The Door, in order to expand access to their services.

 

2. Approve a further variation of the council’s contract with CGL described in Recommendation 1(a) above by increasing the charges payable thereunder in order to continue to fund the initiatives described in Recommendation 1(a) during financial year 2023/24.

 

3. Approve a further variation of the council’s contract with Prospects described in Recommendation 1(c) above by increasing the charges payable thereunder in order to continue to fund the additional staff described in Recommendation 1(c) during financial year 2023/24.

 

4. Delegate authority to the Director of Public Health, in consultation with the Cabinet portfolio holder for Public Health and Communities, to allocate, at their discretion SSMTRG funding made available by OHID for use in financial year 2024/25 (the 2024/25 SSMTRG) (amounting to £1,130,000) to the council’s contracted providers of the adult community drug and alcohol services and other organisations supporting either adults or young people in relation to substance misuse in financial year 2024/25 for the purpose of meeting the objectives of the National Drugs Strategy 2021, in accordance with Government SSMTRG guidance, UK subsidy control regime requirements and public procurement law requirements.